Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Howell

Showing results (131-140 of 260) with videos related to

Pageof 26
Sort By:
British Journal of Cancer|January 1, 1996
Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153D P Gately, A Sharma, R D Christen, et al.
Cancer Treatment Reports|June 1, 1986
Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycinM Markman, S Cleary, W Lucas, et al.
Cancer Research|January 1, 1988
cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cellsP A Andrews, S Velury, S C Mann, et al.
Cancer Research|August 1, 1987
Multivesicular liposomes containing 1-beta-D-arabinofuranosylcytosine for slow-release intrathecal therapyS Kim, D J Kim, M A Geyer, et al.
International Journal of Cancer|November 15, 1974
Cell interactions in adoptive immune rejection of a syngeneic tumorS B Howell, J H Dean, E C Esber, et al.
Cancer Research|March 1, 1983
Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protectionS B Howell, C E Pfeifle, W E Wung, et al.
The Laryngoscope|January 1, 1996
"Decadose" effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. II. Clinical studiesK T Robbins, A M Storniolo, W M Hryniuk, et al.
Cancer Communications|January 1, 1990
Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinomaP A Andrews, J A Jones, N M Varki, et al.
Chemico-Biological Interactions|January 1, 1988
Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletionP A Andrews, M A Schiefer, M P Murphy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Extremely prolonged continuous intraperitoneal infusion of cytosine arabinosideS Kirmani, S Zimm, S M Cleary, et al.
Pageof 26

Showing results (131-140 of 260) with videos related to

Sort By:
Pageof 26
British Journal of Cancer|January 1, 1996
Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153D P Gately, A Sharma, R D Christen, et al.
Cancer Treatment Reports|June 1, 1986
Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycinM Markman, S Cleary, W Lucas, et al.
Cancer Research|January 1, 1988
cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cellsP A Andrews, S Velury, S C Mann, et al.
Cancer Research|August 1, 1987
Multivesicular liposomes containing 1-beta-D-arabinofuranosylcytosine for slow-release intrathecal therapyS Kim, D J Kim, M A Geyer, et al.
International Journal of Cancer|November 15, 1974
Cell interactions in adoptive immune rejection of a syngeneic tumorS B Howell, J H Dean, E C Esber, et al.
Cancer Research|March 1, 1983
Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protectionS B Howell, C E Pfeifle, W E Wung, et al.
The Laryngoscope|January 1, 1996
"Decadose" effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. II. Clinical studiesK T Robbins, A M Storniolo, W M Hryniuk, et al.
Cancer Communications|January 1, 1990
Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinomaP A Andrews, J A Jones, N M Varki, et al.
Chemico-Biological Interactions|January 1, 1988
Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletionP A Andrews, M A Schiefer, M P Murphy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Extremely prolonged continuous intraperitoneal infusion of cytosine arabinosideS Kirmani, S Zimm, S M Cleary, et al.
Pageof 26